The New York Genome Center (NYGC) is an independent, nonprofit academic research institution that serves as a multi-institutional hub for collaborative genomic research. Leveraging our strengths in technology development, computational biology, and whole-genome sequencing, our mission is to advance genomic science, and its application to novel biomedical discoveries. NYGC’s areas of focus include the development of computational and experimental genomic methods and disease-focused research to advance the understanding of the genetic basis of cancer, neurodegenerative disease, and neuropsychiatric disease.
During the pandemic, the NYGC has worked with its hospital and academic partners to advance COVID-19 research, monitoring viral variants and exploring the genetic basis of severe disease. We are committed to prioritizing diversity, equity, and inclusion, which is fundamental to promoting greater collaboration, innovation, and discovery. Learn more about NYGC’s Commitment to Diversity, Equity, and Inclusion.
The New York Genome Center Launches the MacMillan Center for the Study of the Non-Coding Cancer Genome
Former New York Genome Center Postdoc, Mat Legut, PhD, Included in New York Business Journal Article
01 / 02
bioRxiv. 2023 Jan. 3.
The genetic architecture of the human skeletal form.
Nature Biotechnology. 2023 Jan. 2.
Integration of whole transcriptome spatial profiling with protein markers.
JCO Precision Oncology. 2022 Dec. 8.